EVENTIDE ASSET MANAGEMENT, LLC

Position in CELC — Celcuity Inc.

CIK 1442891 Boston, MA

Position in CELC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$27,838,631

-$3,447,712 QoQ

Shares Held

243,899

-22.2% QoQ

Ownership

0.500%

of shares outstanding

% of Portfolio

0.46%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

EVENTIDE ASSET MANAGEMENT, LLC holds $1,508,394,820 across 48 Biotechnology names. CELC ranks #18 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MIRM	Mirum Pharmaceuticals, Inc.	1,408,871	$130,151,502
2	SRRK	Scholar Rock Holding Corp	2,197,385	$108,023,446
3	ARGX	Argenx SE	125,657	$91,761,024
4	INSM	INSMED Inc	546,310	$89,332,611
5	AXSM	Axsome Therapeutics, Inc.	519,558	$87,815,693
6	PCVX	Vaxcyte, Inc.	1,374,292	$79,860,108
7	RPRX	Royalty Pharma plc	1,312,534	$62,962,255
8	BLTE	Belite Bio, Inc	357,650	$57,023,716

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$27,838,631	243,899	-22.2%	Shares	Sole	2026-05-15
2025-12-31	$31,286,343	313,679	-71.2%	Shares	Sole	2026-02-13
2025-09-30	$53,786,670	1,088,799	-21.6%	Shares	Sole	2025-11-14
2025-06-30	$18,548,850	1,389,427	+9.8%	Shares	Sole	2025-08-14
2025-03-31	$12,795,751	1,265,653	0.0%	Shares	Sole	2025-05-15
2024-12-31	$16,567,397	1,265,653	-17.5%	Shares	Sole	2025-02-14
2024-09-30	$22,886,850	1,535,000	0.0%	Shares	Sole	2024-11-14
2024-06-30	$25,143,300	1,535,000	+10.4%	Shares	Sole	2024-08-13
2024-03-31	$30,024,000	1,390,000	—	Shares	Sole	2024-05-15
No filing history on record for this holder in this stock.